Home › Asset managers › Compare 2025-2026 › American Century vs Charles Schwab
American Century 2025-2026 · Charles Schwab 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 14,033 | 12,345 | 1,588 | 100 | 88.6% | 88.3% |
| Board proposals | 13,138 | 11,577 | 1,486 | 75 | 88.6% | 88.4% |
| E&S shareholder proposals | 154 | 148 | 6 | 0 | 96.1% | 96.1% |
| Other items | 741 | 620 | 96 | 25 | 86.6% | 85.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,561 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | Charles Schwab |
|---|---|---|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. | June 4, 2026 | Approval of an amendment to our Amended and Restated 2018 Stock Incentive Plan to increase the number of shares reserved for issuance thereunder by 1,200,000 shares. Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| AST SPACEMOBILE, INC. | June 12, 2026 | To approve the non-binding advisory resolution on the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 11 funds |
| ASTRIA THERAPEUTICS, INC. | January 21, 2026 | To cast a vote, on a non-binding, advisory basis, to approve the Merger-related named executive officer compensation as disclosed in the table entitled ''Golden Parachute Compensation'' and its accompanying footnotes which is included in the section of the proxy statement entitled ''The Merger-Interests of Astia's Directors and Executive Officers in the Merger,'' as required by Section 14A of the Securities Exchange Act of 1934, as amended, which was enacted as part of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 5 funds |
| ASTRONICS CORPORATION | May 28, 2026 | To approve the adoption of the Astronics Corporation 2026 Long Term Incentive Plan. Compensation |
Board | For | AGAINST 13 funds |
FOR 5 funds |
| ATEA PHARMACEUTICALS, INC. | June 18, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| ATLAS ENERGY SOLUTIONS INC. | May 7, 2026 | Please indicate your vote, on a non-binding advisory basis, on the Company's Named Executive Officer compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| AUDIOEYE, INC. | June 22, 2026 | To approve, by non-binding advisory vote, the compensation of AudioEye, Inc.'s named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| AVADEL PHARMACEUTICALS PLC | January 12, 2026 | Ordinary resolution to approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| AVANOS MEDICAL,INC. | April 21, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 10 funds |
| AVANOS MEDICAL,INC. | April 21, 2026 | Approval of an amendment to the Company's 2021 Long Term Incentive Plan to allow for the issuance of awards thereunder to the Company's outside directors. Compensation |
Board | For | AGAINST 5 funds |
FOR 8 funds |
| AVEANNA HEALTHCARE HOLDINGS INC. | May 29, 2026 | To approve, on an advisory, non-binding, basis, the compensation paid to the Company's Named Executive Officers identified in the accompanying Proxy Statement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 7 funds |
| AVEPOINT, INC. | May 5, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| AVIAT NETWORKS, INC. | November 5, 2025 | Advisory, non-binding vote to approve the Company's named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| AVIAT NETWORKS, INC. | November 5, 2025 | Approval of Third Amended and Restated 2018 Incentive Plan of the Company. Compensation |
Board | For | AGAINST 6 funds |
FOR 2 funds |
| AVIDITY BIOSCIENCES, INC. | February 26, 2026 | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers in connection with the transactions contemplated by the Merger Agreement and the Separation Agreement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 7 funds |
| AVIDXCHANGE HOLDINGS, INC. | September 16, 2025 | To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to the Company's named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 5 funds |
| AVNET, INC. | November 21, 2025 | Advisory vote on named executive compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| AVNET, INC. | November 21, 2025 | Approval of the 2025 Stock Compensation and Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 8 funds |
| AXOGEN, INC. | June 23, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 6 funds |
| AXSOME THERAPEUTICS, INC. | June 5, 2026 | To approve, by non-binding advisory vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| AZENTA, INC. | January 28, 2026 | To approve an amendment to the Company's 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by 2,750,000. Compensation |
Board | For | AGAINST 5 funds |
FOR 7 funds |
| Aeva Technologies, Inc. | June 18, 2026 | Election of Class II Directors: Hrach Simonian Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 4 funds |
| Aeva Technologies, Inc. | June 18, 2026 | Election of Class II Directors: Stephen Zadesky Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 4 funds |
| Air Products and Chemicals, Inc. | January 28, 2026 | Election of Directors: Tonit M. Calaway Director Elections |
Board | For | FOR 3 funds |
AGAINST 12 funds |
| Albertsons Companies, Inc. | August 7, 2025 | Election of Directors: Sharon Allen Director Elections |
Board | For | AGAINST 3 funds |
FOR 12 funds |
| Alignment Healthcare, Inc. | June 4, 2026 | Election of Directors: David Hodgson Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 4 funds |
| Alignment Healthcare, Inc. | June 4, 2026 | Election of Directors: Jacqueline Kosecoff Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 4 funds |
| Alignment Healthcare, Inc. | June 4, 2026 | Election of Directors: Jody Bilney Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 4 funds |
| Allogene Therapeutics, Inc. | June 18, 2026 | Election of Directors: Deborah Messemer Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 4 funds |
| Allogene Therapeutics, Inc. | June 18, 2026 | Election of Directors: Owen Witte, M.D. Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 4 funds |
| Allogene Therapeutics, Inc. | June 18, 2026 | Election of Directors: Vicki Sato, Ph.D. Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 4 funds |
| Alta Equipment Group Inc. | May 29, 2026 | Election of Directors: Colin Wilson Director Elections |
Board | For | WITHHOLD 4 funds |
FOR 2 funds |
| Amentum Holdings, Inc. | February 6, 2026 | Election of Directors: Barbara L. Loughran Director Elections |
Board | For | AGAINST 1 fund |
FOR 11 funds |
| Amneal Pharmaceuticals, Inc. | May 6, 2026 | Election of Directors: Deb Autor Director Elections |
Board | For | AGAINST 4 funds |
FOR 8 funds |
| Amneal Pharmaceuticals, Inc. | May 6, 2026 | Election of Directors: J. Kevin Buchi Director Elections |
Board | For | AGAINST 4 funds |
FOR 8 funds |
| Amneal Pharmaceuticals, Inc. | May 6, 2026 | Election of Directors: Jeff George Director Elections |
Board | For | AGAINST 4 funds |
FOR 8 funds |
| Amneal Pharmaceuticals, Inc. | May 6, 2026 | Election of Directors: John Kiely Director Elections |
Board | For | AGAINST 4 funds |
FOR 8 funds |
| Amneal Pharmaceuticals, Inc. | May 6, 2026 | Election of Directors: Paul Meister Director Elections |
Board | For | AGAINST 4 funds |
FOR 8 funds |
| Amneal Pharmaceuticals, Inc. | May 6, 2026 | Election of Directors: Shlomo Yanai Director Elections |
Board | For | AGAINST 4 funds |
FOR 8 funds |
| Arcus Biosciences, Inc. | June 11, 2026 | Election of Directors: David Lacey, M.D. Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 5 funds |
| Arcus Biosciences, Inc. | June 11, 2026 | Election of Directors: Nicole Lambert Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 5 funds |
| Ares Management Corporation | June 8, 2026 | Election of Directors: Antoinette Bush Director Elections |
Board | For | AGAINST 3 funds |
FOR 16 funds |
| Ares Management Corporation | June 8, 2026 | Election of Directors: Antony P. Ressler Director Elections |
Board | For | AGAINST 3 funds |
FOR 16 funds |
| Ares Management Corporation | June 8, 2026 | Election of Directors: Ashish Bhutani Director Elections |
Board | For | AGAINST 3 funds |
FOR 16 funds |
| Ares Management Corporation | June 8, 2026 | Election of Directors: Bennett Rosenthal Director Elections |
Board | For | AGAINST 3 funds |
FOR 16 funds |
| Ares Management Corporation | June 8, 2026 | Election of Directors: David B. Kaplan Director Elections |
Board | For | AGAINST 3 funds |
FOR 16 funds |
| Ares Management Corporation | June 8, 2026 | Election of Directors: Dr. Judy D. Olian Director Elections |
Board | For | AGAINST 3 funds |
FOR 16 funds |
| Ares Management Corporation | June 8, 2026 | Election of Directors: Eileen Naughton Director Elections |
Board | For | AGAINST 3 funds |
FOR 16 funds |
| Ares Management Corporation | June 8, 2026 | Election of Directors: Michael J Arougheti Director Elections |
Board | For | AGAINST 3 funds |
FOR 16 funds |
| Ares Management Corporation | June 8, 2026 | Election of Directors: Michael Lynton Director Elections |
Board | For | AGAINST 3 funds |
FOR 16 funds |
| Ares Management Corporation | June 8, 2026 | Election of Directors: Paul G. Joubert Director Elections |
Board | For | AGAINST 3 funds |
FOR 16 funds |
| Ares Management Corporation | June 8, 2026 | Election of Directors: R. Kipp deVeer Director Elections |
Board | For | AGAINST 3 funds |
FOR 16 funds |
| Arrowhead Pharmaceuticals, Inc. | March 19, 2026 | Election of Directors: Michael S. Perry Director Elections |
Board | For | FOR 4 funds |
AGAINST 5 funds |
| Ascent Industries Co. | June 10, 2026 | Election of Directors: Aldo J. Mazzaferro Director Elections |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| Ascent Industries Co. | June 10, 2026 | Election of Directors: Benjamin Rosenzweig Director Elections |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| Ascent Industries Co. | June 10, 2026 | Election of Directors: Henry L. Guy Director Elections |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| Atlassian Corporation | December 2, 2025 | Election of Directors: Michael Cannon-Brookes Director Elections |
Board | For | AGAINST 7 funds |
FOR 7 funds |
| Atlassian Corporation | December 2, 2025 | Election of Directors: Scott Farquhar Director Elections |
Board | For | AGAINST 7 funds |
FOR 7 funds |
| Atlassian Corporation | December 2, 2025 | Election of Directors: Shona L. Brown Director Elections |
Board | For | AGAINST 7 funds |
FOR 7 funds |
| BAKER HUGHES COMPANY | May 19, 2026 | The approval of the Baker Hughes Company 2026 Long-Term Incentive Plan Compensation |
Board | For | AGAINST 15 funds |
FOR 13 funds |
| BANC OF CALIFORNIA, INC. | May 6, 2026 | Approval, on an advisory and non-binding basis, of the compensation paid to the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 5 funds |
| BANK OF MARIN BANCORP | May 27, 2026 | Election of Directors: Russell A. Colombo Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 4 funds |
| BANKFINANCIAL CORPORATION | July 21, 2025 | An advisory, non-binding resolution to approve our executive compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| BANKUNITED, INC. | May 21, 2026 | To approve the BankUnited, Inc. Amended and Restated 2023 Omnibus Equity Incentive Plan. Compensation |
Board | For | AGAINST 9 funds |
FOR 8 funds |
| BARNES & NOBLE EDUCATION, INC. | March 10, 2026 | To vote on an advisory (non-binding) basis to approve executive compensation for named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| BASSETT FURNITURE INDUSTRIES, INC. | March 11, 2026 | PROPOSAL to consider and act on an advisory vote regarding the approval of compensation paid to certain executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 3 funds |
| BAXTER INTERNATIONAL INC. | May 5, 2026 | Advisory Vote to Approve Named Executive Officer Compensation for 2025 Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 17 funds |
| BAXTER INTERNATIONAL INC. | May 5, 2026 | Approval of the Baxter International Inc. Second Amended and Restated 2021 Incentive Plan Compensation |
Board | For | AGAINST 7 funds |
FOR 14 funds |
| BEAM THERAPEUTICS INC. | June 3, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Approval of an amendment to the 2004 Employee and Director Equity-Based Compensation Plan Compensation |
Board | For | AGAINST 12 funds |
FOR 15 funds |
| BELLRING BRANDS, INC. | January 28, 2026 | To consider and vote, on an advisory basis, for the adoption of a resolution approving the compensation of our named executive officers, as such compensation is described under the "Compensation Discussion and Analysis" and "Executive Compensation" sections of this proxy statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 11 funds |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | Election of Directors: Barry J. Bentley Director Elections |
Board | For | WITHHOLD 3 funds |
FOR 9 funds |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | Election of Directors: Brian F. Hughes Director Elections |
Board | For | WITHHOLD 3 funds |
FOR 9 funds |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | Election of Directors: Gregory S. Bentley Director Elections |
Board | For | WITHHOLD 3 funds |
FOR 9 funds |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | Election of Directors: Janet B. Haugen Director Elections |
Board | For | WITHHOLD 3 funds |
FOR 9 funds |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | Election of Directors: Keith A. Bentley Director Elections |
Board | For | WITHHOLD 3 funds |
FOR 9 funds |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | Election of Directors: Nicholas H. Cumins Director Elections |
Board | For | WITHHOLD 3 funds |
FOR 9 funds |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | Election of Directors: Raymond B. Bentley Director Elections |
Board | For | WITHHOLD 3 funds |
FOR 9 funds |
| BGC GROUP INC. | November 12, 2025 | Approval, on an advisory basis, of executive compensation. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 10 funds |
| BICARA THERAPEUTICS INC. | June 9, 2026 | To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal. Christopher Bowden, M.D. Director Elections |
Board | For | WITHHOLD 4 funds |
FOR 4 funds |
| BILL HOLDINGS, INC. | December 11, 2025 | To approve, on an advisory basis, the compensation of our Named Executive Officers (Say-on-Pay). Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 9 funds |
| BIO-TECHNE CORP | October 30, 2025 | Approve, on an advisory basis, the compensation of our executive officers. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 18 funds |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. Compensation |
Board | For | AGAINST 2 funds |
FOR 6 funds |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To hold a non-binding, advisory vote regarding executive compensation. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 7 funds |
| BIOHAVEN LTD | April 28, 2026 | A non-binding advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| BIOLIFE SOLUTIONS, INC. | August 20, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 5 funds |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended. Compensation |
Board | For | AGAINST 10 funds |
FOR 13 funds |
| BK TECHNOLOGIES CORPORATION | June 18, 2026 | To approve, on an advisory, non-binding basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| BLACKLINE, INC. | May 7, 2026 | Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 5 funds |
| BLACKROCK, INC. | May 20, 2026 | Approval, in a non-binding advisory vote, of the compensation for named executive officers. Say-on-Pay |
Board | For | FOR 17 funds |
AGAINST 17 funds |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Advisory Vote on Executive Compensation Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 8 funds |
| BLUE BIRD CORPORATION | March 11, 2026 | To approve the Blue Bird Corporation Amended and Restated 2015 Omnibus Equity Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 5 funds |
| BLUELINX HOLDINGS | May 14, 2026 | Proposal to approve an Amendment to the 2021 Long-Term Incentive Plan to increase the number of shares of common stock reserved for Issuance under the plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 7 funds |
| BOOT BARN HOLDINGS, INC. | August 27, 2025 | To vote on a non-binding advisory resolution to approve the compensation paid to named executive officers for fiscal 2025 ("say-on-pay"). Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| BRAEMAR HOTELS & RESORTS INC. | December 15, 2025 | To obtain advisory approval of the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 3 funds |
| BRAZE, INC. | June 30, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 5 funds |
| BREAD FINANCIAL HOLDINGS, INC. | May 19, 2026 | ADVISORY VOTE ON EXECUTIVE COMPENSATION Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 10 funds |
| BRIDGEBIO PHARMA, INC. | June 22, 2026 | To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares. Compensation |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| BRIDGEWATER BANCSHARES, INC. | April 28, 2026 | Approve the Bridgewater Bancshares, Inc. 2026 Equity Incentive Plan; and Compensation |
Board | For | AGAINST 6 funds |
FOR 2 funds |
| BRIGHTHOUSE FINANCIAL, INC. | February 12, 2026 | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Brighthouse Financial, Inc.'s named executive officers that is based on or otherwise relates to the Merger; and Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 9 funds |
← Previous Page 2 of 16 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.